US · XWEL · MEDICAL - CARE FACILITIES
XWELL, Inc. (XWEL) intrinsic value and stock valuation
$0.41as of 2026-11-21 · Mkt cap 7.93M
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
XWELL, Inc. DCF and intrinsic value
InvestorsCraft values XWEL with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from XWEL’s statements →
XWELL, Inc. Graham Number
The Graham Number is not defined for negative earnings or book value. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Xcel Brands, Inc. (XELB) $0.35
- Springview Holdings Ltd Class A Ordinary Shares (SPHL) $2.41
- E-Home Household Service Holdings Limited (EJH) $1.11
- NaaS Technology Inc. (NAAS) $1.50
- Interactive Strength Inc. (TRNR) $0.64
- Twin Vee Powercats Co. (VEEE) $6.53
- Meiwu Technology Company Limited (WNW) $1.65
- Cheetah Net Supply Chain Service Inc. (CTNT) $1.46
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $29.2M | $33.9M | $30.1M | $55.9M | $73.7M |
| Operating income | -$-9.36M | -$-16.71M | -$-28.21M | -$-31.16M | $4.11M |
| Net income | -$-16.99M | -$-16.85M | -$-27.74M | -$-32.84M | $3.35M |
| EPSd | -$-3.06M | -$-3.66M | -$-6.64M | -$-7.02M | $638.1K |
| Operating cash flow | -$-8.71M | -$-11.01M | -$-16.07M | -$-24.19M | $14.6M |
| Capital expenditure | -$-2.96M | -$-1.79M | -$-2.37M | -$-6.84M | -$-7.59M |
| Free cash flow | -$-11.68M | -$-12.8M | -$-18.45M | -$-31.02M | $6.97M |
| Total assets | $11.2M | $25.4M | $39M | $70.4M | $127.3M |
| Total debt | $12.5M | $10.8M | $11.1M | $14.1M | $13.8M |
| Net debt | $9.87M | $6.22M | $2.66M | -$-4.93M | -$-91.68M |
| Total equity | -$-12.58M | $7.74M | $21M | $48M | $99.9M |
| Cash and short-term investments | $2.62M | $11.8M | $23.1M | $42.2M | $105.5M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $29.2M | $33.9M | $30.1M | $55.9M | $73.7M |
| Cost of revenue | $22.6M | $25M | $26.4M | $43.9M | $41.4M |
| Gross profit | $6.64M | $8.92M | $3.68M | $12.1M | $32.3M |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $16M | $20.1M | $20.9M | $31.2M | $24.2M |
| Other expenses | $0.00 | $5.54M | $11M | $12M | $4.04M |
| Operating expenses | $16M | $25.6M | $31.9M | $43.2M | $28.2M |
| Cost and expenses | $38.6M | $50.6M | $58.3M | $87.1M | $69.6M |
| Interest income | $660K | $380K | $450K | $380K | $0.00 |
| Interest expense | $130K | $180K | $320K | $460K | $0.00 |
| Depreciation and amortization | $1.78M | $940K | $3.55M | $5.43M | $3.2M |
| Ebitda | -$-14.16M | -$-11.16M | -$-15.75M | -$-19.12M | $8.14M |
| Operating income | -$-9.36M | -$-16.71M | -$-28.21M | -$-31.16M | $4.11M |
| Total other income/expenses, net | -$-6.72M | $270K | $210K | -$-1.41M | -$-1.16M |
| Income before tax | -$-16.08M | -$-16.44M | -$-27.99M | -$-32.57M | $2.95M |
| Income tax expense | $30K | $50K | $40K | $60K | $60K |
| Net income | -$-16.99M | -$-16.85M | -$-27.74M | -$-32.84M | $3.35M |
| Weighted average shares outstanding | $3.34M | $4.6M | $4.18M | $4.68M | $5.58M |
| Weighted average diluted shares outstanding | $5.56M | $4.61M | $4.18M | $4.68M | $5.25M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.62M | $11.8M | $23.1M | $42.2M | $105.5M |
| Net receivables | $1.56M | $1.79M | $1.67M | $2.86M | $610K |
| Inventory | $510K | $500K | $900K | $1.16M | $1.76M |
| Total current assets | $5.91M | $15.3M | $26.6M | $47.3M | $109M |
| Property, plant and equipment, net | $2.7M | $5.22M | $7.11M | $11.9M | $11M |
| Goodwill and intangible assets | $100K | $2.41M | $2.72M | $8.03M | $3.73M |
| Long-term investments | $250K | $90K | $50K | $100K | $720K |
| Total non-current assets | $5.31M | $10M | $12.4M | $23.1M | $18.3M |
| Total assets | $11.2M | $25.4M | $39M | $70.4M | $127.3M |
| Accounts payable | $2.84M | $1.61M | $1.1M | $2.31M | $5.54M |
| Short-term debt | $5.45M | $2.38M | $2.4M | $2.59M | $6.32M |
| Deferred revenue | $1.13M | $1.14M | $860K | $340K | $550K |
| Total current liabilities | $12.9M | $9.22M | $9.33M | $11M | $19.8M |
| Long-term debt | $7.04M | $8.39M | $8.69M | $11.5M | $7.5M |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $10.9M | $8.39M | $8.69M | $11.5M | $7.5M |
| Capital lease obligations | $8.9M | $10.8M | $11.1M | $14.1M | $10.2M |
| Total liabilities | $23.8M | $17.6M | $18M | $22.5M | $27.3M |
| Common stock | $60K | $50K | $40K | $830K | $1.01M |
| Retained earnings | -$-489.7M | -$-472.71M | -$-455.85M | -$-428.11M | -$-395.27M |
| Accumulated other comprehensive income (loss) | -$-1.54M | -$-1.96M | -$-1.92M | -$-530K | -$-310K |
| Total equity | -$-12.58M | $7.74M | $21M | $48M | $99.9M |
| Total investments | $260K | $7.33M | $14.7M | $23.3M | $720K |
| Total debt | $12.5M | $10.8M | $11.1M | $14.1M | $13.8M |
| Net debt | $9.87M | $6.22M | $2.66M | -$-4.93M | -$-91.68M |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | -$-16.11M | -$-16.49M | -$-27.74M | -$-32.63M | $2.89M |
| Depreciation and amortization | $1.78M | $2.27M | $3.55M | $7.27M | $4.92M |
| Stock-based compensation | $1.08M | $890K | $2.32M | $3.87M | $2.86M |
| Change in working capital | -$-2.26M | -$-1.58M | -$-1.92M | -$-9.94M | $1.63M |
| Accounts receivable | $250K | -$-190K | $1.19M | -$-1.83M | -$-1.12M |
| Inventory | -$-10K | $400K | $260K | $590K | -$-1.11M |
| Accounts payable | $1.21M | $390K | -$-490K | -$-3.25M | $6.69M |
| Net cash provided by operating activities | -$-8.71M | -$-11.01M | -$-16.07M | -$-24.19M | $14.6M |
| Investments in property, plant and equipment | -$-2.96M | -$-1.78M | -$-1.91M | -$-6.84M | -$-4.28M |
| Acquisitions, net | $0.00 | $0.00 | -$-1.39M | -$-4.85M | $2.43M |
| Net cash used for investing activities | $4.33M | $5.89M | $5.65M | -$-34.84M | -$-5.16M |
| Common stock issued | $3.75M | $1.35M | $0.00 | $0.00 | $17.1M |
| Common stock repurchased | -$-1.79M | $0.00 | -$-20K | -$-23.86M | -$-7.83M |
| Dividends paid | -$-270K | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for financing activities | $1.94M | $1.36M | $10K | -$-27.38M | $6.35M |
| Net change in cash | -$-2.43M | -$-3.89M | -$-10.6M | -$-86.47M | $15.8M |
| Cash at end of period | $2.87M | $5.3M | $9.19M | $19.8M | $106.3M |
| Operating cash flow | -$-8.71M | -$-11.01M | -$-16.07M | -$-24.19M | $14.6M |
| Capital expenditure | -$-2.96M | -$-1.79M | -$-2.37M | -$-6.84M | -$-7.59M |
| Free cash flow | -$-11.68M | -$-12.8M | -$-18.45M | -$-31.02M | $6.97M |
Line items
Line items
Line items
About XWELL, Inc.
XWELL Inc. functions as a health and wellness services provider, primarily operating within airports. The company delivers its diverse offerings through various brands, including XpresSpa, XpresTest, Treat, and HyperPointe. Its core services feature a range of spa treatments such as massages, nail care, and skincare, further complemented by the sale of spa, travel, and general retail merchandise. Beyond relaxation services, XWELL also manages dedicated wellness centers. These facilities provide crucial health diagnostic services, encompassing COVID-19 screening and testing, rapid tests for various communicable diseases like influenza, RSV, and different flu strains (A&B), alongside seasonal flu vaccinations and other medical diagnostic procedures. To enhance accessibility for the traveling public, the company utilizes an integrated digital platform and a tailored retail selection. As of December 31, 2021, XWELL maintained a significant global presence, with 52 spa and clinic locations spanning 24 airports across the United States, the Netherlands, and the United Arab Emirates. The organization, headquartered in New York, New York, underwent a name change in October 2022, transitioning from its former identity as XpresSpa Group, Inc. to its current designation, XWELL Inc.
- CEO
- Ezra T. Ernst
- Employees
- 175
- Beta
- 1.03
Explore
Frequently asked questions
What is the intrinsic value of XWELL, Inc. (XWEL)?
InvestorsCraft does not currently publish an intrinsic value for XWEL. How the IC value is calculated.
Is XWEL undervalued?
InvestorsCraft does not publish an undervaluation signal for XWEL at this time.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.